Overview
Trigonocephaly-bifid nose-acral anomalies syndrome (also known as Trigonocephaly syndrome, Say-Meyer type or Say-Meyer syndrome) is an extremely rare congenital malformation syndrome characterized by a distinctive combination of craniofacial and limb abnormalities. The condition is named for its three cardinal features: trigonocephaly (a triangular-shaped forehead caused by premature fusion of the metopic suture of the skull), a bifid nose (the nose appears split or notched at its tip), and acral anomalies (abnormalities of the hands and feet, including brachydactyly, syndactyly, or other digital malformations). Additional features may include intellectual disability, short stature, and other craniofacial dysmorphisms. The syndrome primarily affects the skeletal system (particularly the skull and extremities), the craniofacial structures, and potentially the central nervous system. Because of the premature cranial suture fusion, some affected individuals may experience increased intracranial pressure or developmental delays. The condition is present from birth, with the craniosynostosis and facial features typically apparent in the neonatal period. There is no specific cure or targeted therapy for this syndrome. Management is supportive and symptomatic, often involving a multidisciplinary team. Surgical correction of craniosynostosis may be necessary to relieve intracranial pressure and improve skull shape. Reconstructive surgery may be considered for the bifid nose and hand or foot anomalies. Developmental support and early intervention services are recommended for children with intellectual disability or developmental delays. Given the extreme rarity of this condition, only a handful of cases have been described in the medical literature, and long-term outcomes remain poorly characterized.
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Trigonocephaly-bifid nose-acral anomalies syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Trigonocephaly-bifid nose-acral anomalies syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Trigonocephaly-bifid nose-acral anomalies syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Trigonocephaly-bifid nose-acral anomalies syndrome.
Community
No community posts yet. Be the first to share your experience with Trigonocephaly-bifid nose-acral anomalies syndrome.
Start the conversation →Latest news about Trigonocephaly-bifid nose-acral anomalies syndrome
No recent news articles for Trigonocephaly-bifid nose-acral anomalies syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Trigonocephaly-bifid nose-acral anomalies syndrome
What is Trigonocephaly-bifid nose-acral anomalies syndrome?
Trigonocephaly-bifid nose-acral anomalies syndrome (also known as Trigonocephaly syndrome, Say-Meyer type or Say-Meyer syndrome) is an extremely rare congenital malformation syndrome characterized by a distinctive combination of craniofacial and limb abnormalities. The condition is named for its three cardinal features: trigonocephaly (a triangular-shaped forehead caused by premature fusion of the metopic suture of the skull), a bifid nose (the nose appears split or notched at its tip), and acral anomalies (abnormalities of the hands and feet, including brachydactyly, syndactyly, or other digi
How is Trigonocephaly-bifid nose-acral anomalies syndrome inherited?
Trigonocephaly-bifid nose-acral anomalies syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Trigonocephaly-bifid nose-acral anomalies syndrome typically begin?
Typical onset of Trigonocephaly-bifid nose-acral anomalies syndrome is neonatal. Age of onset can vary across affected individuals.